Aurobindo Pharma

Aurobindo Pharma shares surge 2% after US FDA greenlights nasal spray

Aurobindo Pharma shares fall over 5% on US FDA observations on Eugia unit

Aurobindo Pharma Shares Surge as USFDA Grants Favorable Inspection Report for Chitkul Facility

Aurobindo Pharma Surge Nearly 2% on the back of US FDA Approval for Testosterone Cypionate Injection

Aurobindo Pharma shares surge 2.5% after company signs Letter of Intent with Merck & Dohme

Aurobindo Pharma Q1: Revenue increased by 10% YoY, while net profit decreased by 22% to Rs. 540 crore

Results for Aurobindo Pharma's first quarter show an increase of 9.9% from the same time last year to $6,850.5 crore in revenue from operations, according to the pharmaceutical giant.

Stocks to watch: Bharti Airtel, Adani Wilmar, Adani Power, Hero MotoCorp and others

The SGX Nifty suggests a favourable start for the BSE Sensex and NSE Nifty 50. Stocks to watch on Wednesday include Bharti Airtel, Adani Power, Adani Wilmar, and Shree Cement.

Shares of Aurobindo Pharma jump by 3% one day after reaching a 52-week low

Aurobindo Pharma shares increased by almost 3% in early trading on Friday, a day after they hit a 52-week low.

Marquee club Manchester United owners show interest in IPL franchise

Bidding for the team, however, won’t be an easy task considering that BCCI has certain strict eligibility criteria for foreign buys.

Market Closing: Sensex, Nifty slip red, dragged by banks and pharma stocks

The markets slipped down from the day's high and early gains recorded in the exchange, dragged mostly by Banking and Financial sector in the last trading hours.

Stocks in focus: HDFC Life, Aurobindo Pharma, Tata Steel; Nifty gains after facing low in early trade